Patent Assignment
Reel/Frame 054198/0953
Assignment of Assignor's Interest
Recorded: 2020-10-28
Pages: 5
Assignee
BIOCRYST PHARMACEUTICALS, INC.
4505 EMPEROR BLVD., SUITE 200, DURHAM, NORTH CAROLINA, 27703
Covered Property
(1)
Crystalline Salts of a Plasma Kallikrein Inhibitor
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Apr 10, 2023
From: BIOCRYST PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Reel/Frame 063284/0001 →
Release of Grant of Security Interest in Patents
Apr 18, 2023
From: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 063362/0550 →
Patent Security Agreement
Apr 19, 2023
From: BIOCRYST PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 063363/0873 →
Termination and Release of Security Interest in Patent Collateral Recorded at Reel 063363/Frame 0873
Oct 8, 2025
From: BIOPHARMA CREDIT PLC
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 073056/0492 →
Security Interest
Jan 23, 2026
From: BIOCRYST PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 074485/0651 →